So now every research dept in every big pharma is aware of pmcb groundbreaking technology
They were aware of it as soon as Lohr published his 1999 ad hoc studies results. And they promptly discarded it. Never made a move on Austrianova.
yes..they will all be watching for a new technology that will treat an unmet need...I
What unmet need? As for new technology, it isn't a 20 yr old antiquated chemo treatment. Featuring a 30 yr old generic chemo drug which has already failed in 2nd line PC.
I wonder who will be first in line to ante up an offer?
That sound you hear knocking on Kenny's door, will be a squirrel running around in the office walls.
So now every research dept in every big pharma is aware of pmcb groundbreaking technology...and they are all keeping an eye on FDA lifting the hold and letting pmcb perform its clinical trial...yes..they will all be watching for a new technology that will treat an unmet need..
Okay.
FDA lifting the hold. Everyone is keeping their eye on this? Are you sure? Links to this assertion?
A sub penny stock with a 20 year old ad hoc study done abroad and a limited patient sampling.....
I'll take my shot with a $0.20 stock with over 10 years of verified data. Thanks anyway.......
Or will there be a bidding war? Do I hear .005 will anyone start the bidding at .005? Will anyone start the bidding at .0005? Do I hear .0005 anyone? Just be ready. 15+ years and counting patient or...